Relax HCIT… We aren’t members of that exclu
Post# of 148050
(Total Views: 638)
Posted On: 11/07/2021 4:40:15 PM
Relax HCIT…
We aren’t members of that exclusive group of big Pharma yet… and I say yet.
It doesn’t mean we will not ever become members of the club. There apparently is some prerequisites we need to have in place first to achieve that membership. You’re guess is as good as mine on what we absolutely need but to me it revolves around money… and enough money to be able to jump through all the hoops.
When Frodo steered us to Brazil he gave our little company new life and that was a huge change for us to go international and not accepting the challenges of only the FDA . With being pushed off time after time with things they would like to see. Making it seem like it was a planned delay of our BLA for Duel HIV. I feel we will get more of a fair shake in Brazil or any other country than we do here at home in the USA.
If you look at the possibilities now and see how an approval works for us in Brazil and then the following countries with a domino effect… then we can judge our potential for revenue enough to maybe physically push our way into the US market with the much needed monies to do it right and quickly. Because I believe it only takes money and lots of it to get our trials done here in faster more realistic timelines.
Right now the majority of the patients are still trying big pharmas drugs instead of our and big Pharma pays more to get those patients. We have a hard time competing with other drugs not because we can’t save lives but because the money machine is beating us down. This is what I believe the biggest issue. Money/revenue is everything.
When we have more money to put towards trials and acquiring patients we will level the playing field. Then after a few approvals we won’t be that red headed step child any longer. ( I had those red highlights… so it’s personal) We will have come of age as a company and our approvals will come fast and often. How can we argue that we will not become a platform drug? Just have faith in our management for the direction they chose and see why it was the right choice considering the challenges we faced here.
Being an optimist is hard sometimes but seeing the potential for this company is very easy. Seeing the challenges is the problem with a moving target. I see so many shots on goal. Having 5 possible BTD’s in the next 6 months maybe 2 EUA’s just gives us the great odds of an approval or two before the end of 2022. Some could happen much sooner. I am a believer and will not let people like Craig poo poo on the possibilities with his negative perceptions and his attacks on our companies management. So we are doing just fine. We all have to realize that we have a champagne drug that we are trying to get across a finish line on a beer budget. It makes it tough. This is why we need to finance our 200 million shares so we can continue our path to success. It’s not only something we should do it’s something we have to do. The other options are far to risky. I am not a big fan of taking the risky way. Putting myself in the position of failure when we don’t have to. So voting the company line of everything they asked for is the best path. The one we need if we really want success.
When I use Frodo as a nickname for Nader I use it as a compliment. The protector our our precious Leronlimab… our precious…
file:///var/mobile/Library/SMS/Attachments/64/04/6FEB32D5-8821-4443-AA6C-A5DE15ED8A07/IMG_3422.JPG
We aren’t members of that exclusive group of big Pharma yet… and I say yet.
It doesn’t mean we will not ever become members of the club. There apparently is some prerequisites we need to have in place first to achieve that membership. You’re guess is as good as mine on what we absolutely need but to me it revolves around money… and enough money to be able to jump through all the hoops.
When Frodo steered us to Brazil he gave our little company new life and that was a huge change for us to go international and not accepting the challenges of only the FDA . With being pushed off time after time with things they would like to see. Making it seem like it was a planned delay of our BLA for Duel HIV. I feel we will get more of a fair shake in Brazil or any other country than we do here at home in the USA.
If you look at the possibilities now and see how an approval works for us in Brazil and then the following countries with a domino effect… then we can judge our potential for revenue enough to maybe physically push our way into the US market with the much needed monies to do it right and quickly. Because I believe it only takes money and lots of it to get our trials done here in faster more realistic timelines.
Right now the majority of the patients are still trying big pharmas drugs instead of our and big Pharma pays more to get those patients. We have a hard time competing with other drugs not because we can’t save lives but because the money machine is beating us down. This is what I believe the biggest issue. Money/revenue is everything.
When we have more money to put towards trials and acquiring patients we will level the playing field. Then after a few approvals we won’t be that red headed step child any longer. ( I had those red highlights… so it’s personal) We will have come of age as a company and our approvals will come fast and often. How can we argue that we will not become a platform drug? Just have faith in our management for the direction they chose and see why it was the right choice considering the challenges we faced here.
Being an optimist is hard sometimes but seeing the potential for this company is very easy. Seeing the challenges is the problem with a moving target. I see so many shots on goal. Having 5 possible BTD’s in the next 6 months maybe 2 EUA’s just gives us the great odds of an approval or two before the end of 2022. Some could happen much sooner. I am a believer and will not let people like Craig poo poo on the possibilities with his negative perceptions and his attacks on our companies management. So we are doing just fine. We all have to realize that we have a champagne drug that we are trying to get across a finish line on a beer budget. It makes it tough. This is why we need to finance our 200 million shares so we can continue our path to success. It’s not only something we should do it’s something we have to do. The other options are far to risky. I am not a big fan of taking the risky way. Putting myself in the position of failure when we don’t have to. So voting the company line of everything they asked for is the best path. The one we need if we really want success.
When I use Frodo as a nickname for Nader I use it as a compliment. The protector our our precious Leronlimab… our precious…
file:///var/mobile/Library/SMS/Attachments/64/04/6FEB32D5-8821-4443-AA6C-A5DE15ED8A07/IMG_3422.JPG
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼